Latest filing published 03 Feb 2026 for UGI CORP.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -87.4%Entry US$24.10 · Close at T+365 US$3.03
- -39.5%Entry US$30.90 · Close at T+365 US$18.70
- -81.2%Entry US$134.20 · Close at T+365 US$25.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kelly A. Romano: trading record in brief
This profile gathers the share dealings of Kelly A. Romano across 3 companies, led by Dorman Products, Inc., UGI Corp and LeonaBio, Inc. We count 29 filings; the first trade dates from 9 November 2017 and the latest from 30 January 2026.
No open-market sale appears; the market trades are 4 purchases worth €282k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 25 share grants.
The median purchase comes to €78k. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -78.7%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 3 February 2026: a share grant, in UGI Corp. The most recent open-market purchase was published on 25 June 2024, 867 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kelly A. Romano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,364 shares0UGI Common StockSEC:0001722055-26-000002:0
- 1,070 shares0Common StockSEC:0001628280-25-029319:0
- 46 shares@ US$132.0328.2% of flowCommon StockSEC:0001628280-25-026762:0
- 5,695 shares0UGI Common StockSEC:0001415889-25-002992:0
- 15,000 shares@ US$2.258111.2% of flowCommon StockSEC:0001415889-24-018177:0Canonical exit: 19 Sept 2024 (T+90)
- 27,400 shares@ US$2.415321.9% of flowCommon StockSEC:0001415889-24-018177:1Canonical exit: 22 Sept 2024 (T+90)
- 1,471 shares0Common StockSEC:0001628280-24-026499:0
- 47 shares@ US$91.3320.6% of flowCommon StockSEC:0001628280-24-024467:0
- 4,470 shares0UGI Common StockSEC:0000884614-24-000026:0
- 1,510 shares0Common StockSEC:0001209191-23-033611:0
- 38 shares@ US$86.5415.9% of flowCommon StockSEC:0001209191-23-031348:0
- 2,600 shares0UGI Common StockSEC:0000884614-23-000015:0
- 30,000 shares@ US$3.2933.3% of flowCommon StockSEC:0001209191-22-060128:0Canonical exit: 2 Mar 2023 (T+90)
- 1,223 shares0Common StockSEC:0001209191-22-033437:0
- 33 shares@ US$98.0615.8% of flowCommon StockSEC:0001209191-22-032399:0
- 8,000 shares@ US$13.1133.6% of flowCommon StockSEC:0001209191-22-022001:0Canonical exit: 29 Jun 2022 (T+90)
- 2,300 shares0UGI Common StockSEC:0001209191-22-007219:0
- 6,050 shares0UGI Common StockSEC:0001209191-22-005962:0
- 1,064 shares0Common StockSEC:0001209191-21-037508:0
- 44 shares@ US$103.0319.5% of flowCommon StockSEC:0001209191-21-033031:0
- 2,870 shares0UGI Common StockSEC:0001209191-21-006920:0
- 36 shares@ US$66.6710.0% of flowCommon StockSEC:0001209191-20-041071:0
- 1,429 shares0Common StockSEC:0001209191-20-033806:0
- 2,350 shares0UGI Common StockSEC:0001209191-20-004858:0
- 1,158 shares0Common StockSEC:0001209191-19-040808:1
25 of 29 declarations
